Objectives of HARP

The research programme will comprise of three interlinked studies:

Study 1 will be a cross-sectional study of HPV and cervical neoplasia screening among 1,200 women attending HIV care centres.

Study 2 will prospectively follow a cohort of 1,200 women recruited in Study 1 for a duration of 18 months in order to evaluate the performance of screening tests to predict the development or resurrence of cervical neoplasia.

Study 3 will be a modelling study using data from the first two epidemiological studies to determine the cost-effectiveness of the various screening of triage strategies.